The relationship between sarcopenia and non-alcoholic fatty liver disease The Korean sarcopenic obesity study
Hepatology; Vol. 58 Issue 3; DOI: 10.1002/hep.26716
Ho Cheol Hong 1,
Soon Young Hwang 2,
Hae Yoon Choi 1,
Hye Jin Yoo 1,
Ji A Seo 1,
Sin Gon Kim 1,
Nan Hee Kim 1,
Sei Hyun Baik 1,
Dong Seop Choi 1,
Kyung Mook Choi 1,*
1 Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea
2 Department of Biostatistics, College of Medicine, Korea University, Seoul, Korea
*Address all correspondence and reprint requests to: Dr. Kyung Mook Choi, Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, 80 Guro-Dong, Guro-Gu, Seoul 152-050, Korea. E-mail: medica7 at gmail.com, Tel.: 822-2626-3043, Fax: 822-2626-1096
Previous studies have shown that non-alcoholic fatty liver disease (NAFLD) and sarcopenia may share pathophysiological mechanisms, such as insulin resistance, inflammation, vitamin D deficiency, and decreased physical activity. However, their direct relationship has not been investigated. The association between NAFLD and sarcopenia was examined in 452 apparently healthy adults enrolled in the Korean Sarcopenic Obesity Study (KSOS), an ongoing prospective observational cohort study. The liver attenuation index (LAI), which measured using abdominal computed tomography (CT), was used as a parameter for the diagnosis of NAFLD. Sarcopenia was defined using a skeletal muscle mass index (SMI) [SMI (%) = total skeletal muscle mass (kg) / weight (kg) x 100] that was measured by dual energy X-ray absorptiometry (DXA). After adjusting for age and sex, both SMI and LAI were negatively correlated with the homeostasis model assessment of insulin resistance (HOMA-IR) (P<0.001) and high sensitivity C-reactive protein (hsCRP) (P<0.001) as well as brachial-ankle pulse wave velocity (baPWV), an indicator of arterial stiffness. Furthermore, SMI and LAI had positive relationships with HDL-cholesterol, but both had a negative relationship with triglyceride, alanine aminotransferase (ALT), and total body fat. In a multiple logistic regression analysis, the odds ratio for NAFLD risk was 5.16 (95% CI = 1.63-16.33) in the lowest quartile of SMI compared to the highest after adjusting for potential confounding factors.
Conclusion: Individuals with lower muscle mass exhibited increased risk of NAFLD.
This result may provide a novel insight into the mechanism linking between sarcopenia and NAFLD.
Copyright © 2013 American Association for the Study of Liver Diseases
See also Vitamin D Life
- Search Vitamin D Life for Sarcopenia 90 hits as of Sept 2013
- Search Vitamin D Life for NAFLD OR "fatty liver” 354 items as of Feb 2015
- Strong association of non alcoholic fatty liver disease and low vitamin D
- Fatty liver disease weakly associated with low vitamin D – meta-analysis 2013
- Sarcopenia (muscle loss) and Vitamin D
- Vitamin D and bicarbonate perhaps synergistically reduce muscle loss – June 2013
- Vitamin D and Muscles
- Overview Fractures and Falls and Vitamin D
- Fatty Liver Disease in 40 percent of seniors (seniors often have low vitamin D)
- Loss of muscle strength –sarcopenia – one of the suspects is vitamin D – Aug 2012 which has the following graphic